Valencia-Ramos Juan, Arnaez Juan, Benito José Manuel, Mirás Alicia, Ochoa Carlos, Beltrán Sagrario
a Paediatric Intensive Care Unit , Hospital Universitario de Burgos , Burgos , Spain.
b Department of Neonatology , Hospital Universitario de Burgos , Burgos , Spain.
Exp Lung Res. 2019 Feb-Mar;45(1-2):13-21. doi: 10.1080/01902148.2019.1599084. Epub 2019 Apr 22.
The use of a nebulizer paired with high-flow nasal cannulas (HFNC) has been proposed for drug delivery in bronchiolitis. Particle size nebulized is a relevant factor determining the efficacy of the nebulization. We replicated in vitro the theoretical parameters most widely used in bronchiolitis and we compared the size of the droplet nebulized with a standard nebulizer and a nebulizer integrated into HFNC. We used laser diffraction to analyze the particle size nebulized (volume median diameter Dv50). The standard system was a jet nebulizer connected to a facemask with a flow rate of 8 L/min (JN). Three designs were used as nebulizers integrated into HFNC: a vibrating mesh nebulizer set 1) before (HFNC-BH) and 2) after (HFNC-AH) the humidifier, and 3) a jet nebulizer connected before the nasal cannula (HFNC-BNC). HFNC was used with neonatal (3-8 L/min) and infant cannulas (8-15 L/min). Droplet size was similar among the three drugs studied. A lower particle size was obtained when using the nebulization system integrated into HFNC compared to the standard nebulizer, regardless of the flow rate and the nasal cannula used when the position of the nebulizer was before the nasal cannula ( < 0.05): 6.89 µm (JN), 2.49 µm (HFNC-BNC 3 L/min), 2.59 µm (HFNC-BNC 5 L/min), 2.44 µm (HFNC-BNC 8 L/min), 3.22 µm (HFNC-BNC 10 L/min), 3.23 µm (HFNC-BNC 13 L/min), 3.16 µm (HFNC-BNC 15 L/min). The particle size was lower in HFNC-BF compared to the HFNC-AH using neonatal nasal cannula (3-8 L/min) ( < 0.05). The use of a nebulizer integrated with HFNC has shown promising results in an experimental scenario of bronchiolitis. The particle size achieved with the nebulizer placed before the humidifier is equivalent to the one obtained via conventional nebulization, and it is even smaller when the integrated nebulizer is placed before the nasal cannulas.
有人提出将雾化器与高流量鼻导管(HFNC)配合使用来治疗细支气管炎。雾化颗粒大小是决定雾化效果的一个重要因素。我们在体外复制了细支气管炎中最广泛使用的理论参数,并比较了标准雾化器和集成在HFNC中的雾化器所雾化的液滴大小。我们使用激光衍射分析雾化颗粒大小(体积中值直径Dv50)。标准系统是一个连接到面罩、流速为8升/分钟的喷射雾化器(JN)。三种设计用作集成在HFNC中的雾化器:1)一种振动网式雾化器置于加湿器之前(HFNC-BH),2)置于加湿器之后(HFNC-AH),3)一个喷射雾化器连接在鼻导管之前(HFNC-BNC)。HFNC与新生儿鼻导管(3-8升/分钟)和婴儿鼻导管(8-15升/分钟)配合使用。在所研究的三种药物中,液滴大小相似。与标准雾化器相比,当雾化器位于鼻导管之前时,无论流速和使用的鼻导管如何,使用集成在HFNC中的雾化系统可获得更低的颗粒大小(<0.05):6.89微米(JN)、2.49微米(HFNC-BNC 3升/分钟)、2.59微米(HFNC-BNC 5升/分钟)、2.44微米(HFNC-BNC 8升/分钟)、3.22微米(HFNC-BNC 10升/分钟)、3.23微米(HFNC-BNC 13升/分钟)、3.16微米(HFNC-BNC 15升/分钟)。与使用新生儿鼻导管(3-8升/分钟)的HFNC-AH相比,HFNC-BF中的颗粒大小更低(<0.05)。在细支气管炎的实验场景中,将雾化器与HFNC集成使用已显示出有前景的结果。置于加湿器之前的雾化器所达到的颗粒大小与通过传统雾化获得的颗粒大小相当,而当集成雾化器置于鼻导管之前时,颗粒大小甚至更小。